Contact your GP or diabetes specialist if you experience : Persistent nausea or vomiting after restarting GLP-1 medication Difficulty maintaining adequate nutrition or hydration Unexplained abdominal pain or bloating Blood glucose levels outside your target range Your healthcare team will provide individualised guidance based on your specific circumstances, ensuring that resumption of GLP-1 therapy supports both your diabetes management goals and surgical recovery
Role of Carnitine Transporters in Cancers Changes in expression and/or activity of carnitine transporters in plasma or intracellular membranes are expected, especially in those cancers characterized by either an increased or a decreased utilization of fatty acids
Mazdutide needs longer-term data at higher doses to demonstrate comparable sustainability
More energy, clearer thinking, better sleep. Marcus T
Quality, dosing, route of administration, and medical supervision matter greatly
Vetting MW, Park CH, Hegde SS, Jacoby GA, Hooper DC, Blanchard JS
